Cardiovascular Journal of Africa: Vol 27 No 2 (March/April 2016)

56 / 72

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 2, March/April 2016 110 AFRICA
2015.
17. Dekker GA. Management of preeclampsia. Pregnancy Hypertens 2014;
4(3): 246–247.
18. Sircar M, Thadhani R, Karumanchi SA. Pathogenesis of preeclampsia.
Curr Opin Nephrol Hypertens 2015; 24(2): 131–138.
19. Hytten F, Chamberlain G. Clinical Physiology in Obstetrics. Oxford:
Blackwell Scientific, 1980.
20. Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemody-
namics in normal and preeclamptic pregnancies: a longitudinal study. Obstet
Gynecol 1990; 76(6): 1061–1069.
21. Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM.
Maternal–perinatal outcome associated with the syndrome of hemolysis,
elevated liver enzymes, and low platelets in severe preeclampsia–eclampsia.
Am J Obstet Gynecol 1986; 155(3): 501–507.
22. Belfort M, Anthony J, Kirshon B. Respiratory function in severe gestational
proteinuric hypertension: the effects of rapid volume expansion and subse-
quent vasodilatation with verapamil. Br J Obstet Gynecol 1991; 98(10):
964–972.
23. Visser W, Wallenburg H. Central hemodynamic observations in untreated
preeclamptic patients. Hypertension1991; 17(6 Pt 2): 1072–1077.
24. Belfort MA, Anthony J, Saade GR, Wasserstrum N, Johanson R, Clark S,
et al. The oxygen consumption/oxygen delivery curve in severe preeclamp-
sia: evidence for a fixed oxygen extraction state. Am J Obstet Gynecol 1993;
169(6): 1448–1455.
25. Belfort M, Akovic K, Anthony J, Saade G, Kirshon B, Moise K. The
effect of acute volume expansion and vasodilatation with verapamil on
uterine and umbilical artery Doppler indices in severe preeclampsia. J Clin
Ultrasound 1994; 22(5): 317–325.
26. Khong T, Pearce J, Robertson W. Acute atherosis in preeclampsia: maternal
determinants and fetal outcome in the presence of the lesion. Am J Obstet
Gynecol 1987; 157(2): 360–363.
27. Richards A, Graham F, Bullock R. Clinicopathological study of neuro-
logical complications due to hypertensive disorders of pregnancy. J Neurol
Neurosurg Psychiat 1988; 51(3): 416–421.
28. Gaber LW, Spargo BH, Lindheimer MD. Renal pathology in pre-eclampsia.
Bailliere’s Clin Obstet Gynaecol 1994; 8(2): 443–468.
29. Postma IR, Slager S, Kremer HP, de Groot JC, Zeeman GG. Long-term
consequences of the posterior reversible encephalopathy syndrome in
eclampsia and preeclampsia: a review of the obstetric and nonobstetric
literature. Obstet Gynecol Surv 2014; 69(5): 287–300.
30. O’Dwyer SL, Gupta M, Anthony J. Pulmonary edema in pregnancy and
the puerperium: a cohort study of 53 cases. J Perinatal Med 2015; 43(6):
675–681.
31. Belfort MA, Varner MW, Dizon-Townson DS, Grunewald C, Nisell H.
Cerebral perfusion pressure, and not cerebral blood flow, may be the critical
determinant of intracranial injury in preeclampsia: a new hypothesis. Am J
Obstet Gynecol 2002; 187(3): 626–634.
32. Douglas KA, Redman C. Eclampsia in the United Kingdom. Br Med J
1994; 309(6966): 1395–1400.
33. Belfort M, Anthony J, Buccimazza A, Davey D. Hemodynamic changes
associated with intravenous infusion of the calcium antagonist verapamil in
the treatment of severe gestational proteinuric hypertension. Obstet Gynecol
1990; 75(6): 970–974.
34. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJvW. Aggressive or
expectant management for patients with severe preeclampsia between 28–34
weeks’ gestation: a randomized controlled trial. Obstet Gynecol 1990 76(6):
1070–1075.
35. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant
management of severe preeclampsia at 28 to 32 weeks’ gestation: a rand-
omized controlled trial. Am J Obstet Gynecol 1994; 171(3): 818–822.
36. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Library
1996: 1: 1–8.
37. The Eclampsia Trial collaberative group. Which anticonvulsant for women
with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet
1995; 345(8963): 1455–1463.
38. The Magpie Trial collaberative group. Do women with pre-eclampsia,
and their babies, benefit from magnesium sulphate? The Magpie Trial: a
randomised placebo-controlled trial. Lancet 2002; 359 (9321): 1877–1890.
39. Anthony J, Johanson R. Critical care in pregnancy. Curr Obstet Gynaecol
1996; 6(2): 98–104.
40. Sibai BM. Imitators of severe preeclampsia. Obstet Gynecol 2007; 109(4):
956–966.
41. Linton D, Anthony J. Critical care management of severe pre-eclampsia.
Intensive Care Med 1997;23(3): 248–255.
42. Drakeley AJ, Le Roux PA, Anthony J, Penny. Acute renal failure complicat-
ing severe preeclampsia requiring admission to an obstetric intensive care
unit. Am J Obstet Gynecol 2002; 186(2): 253–256.
43. Chandran R, Serra‐Serra V, Redman CW. Spontaneous resolution of pre‐
eclampsia‐related thrombocytopenia. Br J Obstet Gynaecol 1992; 99(11):
887–890.
44. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA.
Maternal morbidity and mortality in 442 pregnancies with hemolysis,
elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet
Gynecol 1993; 169(4): 1000–1006.
45. Gilbert WM, Towner DR, Field NT, Anthony J. The safety and utility of
pulmonary artery catheterization in severe preeclampsia and eclampsia. Am
J Obstet Gynecol 2000; 182(6): 1397–1403.
46. Hankins GD, Wendel GD, Cunningham FG, Leveno KJ. Longitudinal
evaluation of hemodynamic changes in eclampsia. Am J Obstet Gynecol
1984; 150(5): 506–512.
47. Irgens HU, Roberts JM, Reisæter L, Irgens LM, Lie RT. Long-term mortal-
ity of mothers and fathers after pre-eclampsia: population-based cohort
study. Pre-eclampsia and cardiovascular disease later in life: who is at risk?
Br Med J 2001; 323(7323): 1213–1217.
48. Vikse BE, Irgens LM, Leivestad T, Skjærven R, Iversen BM. Preeclampsia
and the risk of end-stage renal disease. New Engl J Med 2008. 359(8):
800–809.
49. Nicolaides KH. Turning the pyramid of prenatal care. Fetal Diagn Ther
2011; 29(3): 183–196.
50. Duley L, Henderson-Smart D, Meher S, King J. Antiplatelet agents for
preventing pre-eclampsia and its complications. Cochrane Database Syst
Rev 2007; 4: 1–121.
51. Roberts JM, Catov JM. Aspirin for pre-eclampsia: compelling data on
benefit and risk. Lancet 2007; 369 (9575): 1765–1766.
52. Hofmeyr G, Duley L, Atallah A. Dietary calcium supplementation for
prevention of pre‐eclampsia and related problems: a systematic review and
commentary. Br J Obstet Gynaecol 2007; 114(8): 933–943.
53. Chappell LC, Duckworth S, Seed PT, Griffin M, Myers J, Mackillop L, et
al. Diagnostic accuracy of placental growth factor in women with suspected
preeclampsia: a prospective multicenter study. Circulation 2013; 128 (19):
2121–1231.
54. Sliwa K, Anthony J. Cardiac Drugs in Pregnancy. London: Springer Verlag,
2014.
55. Sliwa K, Libhaber E, Elliott C, Momberg Z, Osman A, Zühlke L, et al .
Spectrum of cardiac disease in maternity in a low-resource cohort in South
Africa. Heart 2014: 100 : 1967–1974.
56. Davey D, MacGillivray I. The classification and definition of the hyper-
tensive disorders of pregnancy: proposals submitted to the International
Society for the Study of Hypertension in Pregnancy. Part B: Hypertension
in pregnancy . Clin Exp Hypertens 1986; 5(1): 97–133.